Marleen Luten

1.1k total citations
12 papers, 891 citations indexed

About

Marleen Luten is a scholar working on Hematology, Physiology and Biochemistry. According to data from OpenAlex, Marleen Luten has authored 12 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Physiology and 4 papers in Biochemistry. Recurrent topics in Marleen Luten's work include Erythrocyte Function and Pathophysiology (7 papers), Blood groups and transfusion (5 papers) and Blood transfusion and management (4 papers). Marleen Luten is often cited by papers focused on Erythrocyte Function and Pathophysiology (7 papers), Blood groups and transfusion (5 papers) and Blood transfusion and management (4 papers). Marleen Luten collaborates with scholars based in Netherlands and Austria. Marleen Luten's co-authors include G.J.C.G.M. Bosman, Bregt Roerdinkholder‐Stoelwinder, Harry Bos, Willem J. de Grip, Edwin Lasonder, V.M.J. Novotný, Nicolaas Schaap, Wim L.J. van Putten, Rong Zhu and Ulrich Salzer and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Marleen Luten

12 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marleen Luten Netherlands	9	499	331	295	244	161	12	891
V.M.J. Novotný Netherlands	16	550 1.1×	333 1.0×	419 1.4×	294 1.2×	193 1.2×	28	1.1k
Yvonne A. M. Groenen‐Döpp Netherlands	6	506 1.0×	69 0.2×	158 0.5×	272 1.1×	306 1.9×	8	802
Sip Dinkla Netherlands	9	202 0.4×	38 0.1×	112 0.4×	116 0.5×	163 1.0×	12	460
Lawrence N. Button United States	10	74 0.1×	75 0.2×	118 0.4×	96 0.4×	99 0.6×	14	621
Ram Chillar United States	12	67 0.1×	47 0.1×	231 0.8×	58 0.2×	171 1.1×	17	589
JL Spivak United States	13	205 0.4×	63 0.2×	524 1.8×	70 0.3×	136 0.8×	24	732
TA Lane United States	11	75 0.2×	94 0.3×	158 0.5×	47 0.2×	74 0.5×	18	467
Virginia C. Canale United States	11	60 0.1×	61 0.2×	244 0.8×	114 0.5×	143 0.9×	20	841
Kenneth N. Vanek United States	13	57 0.1×	172 0.5×	49 0.2×	159 0.7×	133 0.8×	25	741
RF Zwaal Netherlands	9	142 0.3×	16 0.0×	425 1.4×	128 0.5×	292 1.8×	10	779

Countries citing papers authored by Marleen Luten

Since Specialization

Citations

This map shows the geographic impact of Marleen Luten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen Luten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen Luten more than expected).

Fields of papers citing papers by Marleen Luten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen Luten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen Luten. The network helps show where Marleen Luten may publish in the future.

Co-authorship network of co-authors of Marleen Luten

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen Luten. A scholar is included among the top collaborators of Marleen Luten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen Luten. Marleen Luten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Lugtenburg, Pieternella J., Josée M. Zijlstra, Jeanette K. Doorduijn, et al.. (2015). Rituximab-Pecc Induction Followed By 90y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or Have Failed ASCT: Results from a Phase II HOVON Study. Blood. 126(23). 2707–2707. 1 indexed citations

2.

Kluin‐Nelemans, Hanneke C., Marinus van Marwijk Kooy, Pieternella J. Lugtenburg, et al.. (2011). Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma. Annals of Oncology. 22(7). 1595–1600. 55 indexed citations

3.

Putten, Wim L.J. van, Peter A.W. te Boekhorst, Martin R. Schipperus, et al.. (2010). Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. British Journal of Haematology. 150(2). 209–217. 132 indexed citations

4.

Pistorius, Arthur M. A., Marleen Luten, G.J.C.G.M. Bosman, & Willem J. DeGrip. (2009). A single assay for multiple storage‐sensitive red blood cell characteristics by means of infrared spectroscopy. Transfusion. 50(2). 366–375. 5 indexed citations

5.

Bosman, G.J.C.G.M., Edwin Lasonder, Marleen Luten, et al.. (2008). The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion. 48(5). 827–835. 177 indexed citations

6.

Bosman, G.J.C.G.M., Edwin Lasonder, Marleen Luten, et al.. (2008). The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion. 48(5). 827–835. 140 indexed citations

7.

Luten, Marleen, Bregt Roerdinkholder‐Stoelwinder, Nicolaas Schaap, et al.. (2008). Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion. 48(7). 1478–1485. 182 indexed citations

8.

Luten, Marleen, Bregt Roerdinkholder‐Stoelwinder, Eva Rombout‐Sestrienkova, et al.. (2007). Red cell concentrates of hemochromatosis patients comply with the storage guidelines for transfusion purposes. Transfusion. 48(3). 436–441. 16 indexed citations

9.

Salzer, Ulrich, Rong Zhu, Marleen Luten, et al.. (2007). Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion. 48(3). 451–462. 136 indexed citations

10.

Bosman, G.J.C.G.M., et al.. (2005). Storage-related changes in erythrocyte band 3: not a case for the Diego blood group antigens.. PubMed. 51(2). 195–200. 10 indexed citations

11.

Luten, Marleen, et al.. (2004). Survival of the fittest?--survival of stored red blood cells after transfusion.. PubMed. 50(2). 197–203. 36 indexed citations

12.

Luten, Marleen, et al.. (2004). Survival of the fittest? - Survival of stored RBCs after transfusion. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact